SELADELPAR LYSINE

SELADELPAR LYSINE was reported 276 times

SELADELPAR LYSINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC DISEASE DECOMPENSATION 1 0.0357
1 CSF VOLUME INCREASED 1 0.0084
2 SPONTANEOUS BACTERIAL PERITONITIS 1 0.0041
3 BLOOD IMMUNOGLOBULIN M INCREASED 2 0.0033
4 CREATINE KINASE INCREASED 2 0.0026
5 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
6 CARBOHYDRATE ANTIGEN 19-9 INCREASED 1 0.0019
7 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 1 0.0017
8 OPHTHALMIC MIGRAINE 1 0.0014
9 CHOLANGITIS ACUTE 1 0.0013
10 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
11 SMALL INTESTINAL PERFORATION 2 0.0011
12 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
13 BILIRUBIN CONJUGATED INCREASED 2 0.0009
14 BILE DUCT STENOSIS 1 0.0008
15 BLOOD BILIRUBIN ABNORMAL 1 0.0008
16 BILIARY OBSTRUCTION 1 0.0008
17 HYPERTRANSAMINASAEMIA 5 0.0007
18 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
19 EYE ALLERGY 1 0.0006
20 NARCOLEPSY 1 0.0005
21 EXPOSURE VIA BREAST MILK 2 0.0005
22 LICHEN PLANUS 1 0.0004
23 ASPARTATE AMINOTRANSFERASE INCREASED 22 0.0004
24 GASTROINTESTINAL TUBE INSERTION 1 0.0004
25 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
26 EYELID MARGIN CRUSTING 1 0.0003
27 MYELOFIBROSIS 1 0.0003
28 VARICES OESOPHAGEAL 1 0.0003
29 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
30 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
31 PORTAL VEIN THROMBOSIS 1 0.0003
32 VULVOVAGINAL DRYNESS 1 0.0003
33 LYME DISEASE 1 0.0003
34 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
35 AUTOIMMUNE HEPATITIS 2 0.0003
36 THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.0003
37 LIVER TRANSPLANT 1 0.0003
38 HEPATIC NECROSIS 1 0.0003
39 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
40 FUNGAL SKIN INFECTION 1 0.0002
41 LUMBAR VERTEBRAL FRACTURE 1 0.0002
42 SKIN TIGHTNESS 1 0.0002
43 ERYTHEMA OF EYELID 1 0.0002
44 TRANSAMINASES INCREASED 4 0.0002
45 PERIORBITAL SWELLING 1 0.0002
46 BLOOD URIC ACID INCREASED 1 0.0002
47 DECREASED INTEREST 1 0.0002
48 DRUG-INDUCED LIVER INJURY 5 0.0002
49 SWELLING OF EYELID 1 0.0002
50 APPETITE DISORDER 1 0.0002
51 BLOOD BILIRUBIN INCREASED 4 0.0001
52 HEPATIC ENZYME INCREASED 10 0.0001
53 FAECES SOFT 1 0.0001
54 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
55 CHROMATURIA 3 0.0001
56 ANKLE FRACTURE 2 0.0001
57 MULTIPLE ALLERGIES 1 0.0001
58 GALLBLADDER DISORDER 2 0.0001
59 MYOSITIS 1 0.0001
60 THERAPY NON-RESPONDER 5 0.0001
61 HEPATIC STEATOSIS 2 0.0001
62 HEPATIC ENCEPHALOPATHY 1 0.0001
63 ABDOMINAL DISTENSION 11 0.0001
64 CHOLESTASIS 2 0.0001
65 VITREOUS FLOATERS 1 0.0001
66 LIGAMENT SPRAIN 1 0.0001
67 HEPATIC FAILURE 3 0.0001
68 HYPERBILIRUBINAEMIA 1 0.0001
69 INCONTINENCE 1 0.0001
70 EYE PRURITUS 3 0.0001
71 OCULAR DISCOMFORT 1 0.0001
72 HEPATITIS 2 0.0001
73 THERAPY CESSATION 4 0.0001
74 INJECTION SITE INDURATION 1 0.0001
75 ORAL CANDIDIASIS 1 0.0001
76 DIALYSIS 1 0.0001
77 SUBDURAL HAEMATOMA 1 0.0001
78 BRAIN FOG 1 0.0001
79 PRODUCT USE COMPLAINT 1 0.0001
80 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
81 SENSORY DISTURBANCE 1 0.0001
82 BLOOD UREA INCREASED 1 0.0001
83 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
84 HEAD DISCOMFORT 1 0.0001
85 HEPATIC CIRRHOSIS 1 0.0001
86 PRURITUS 20 0.0001
87 ERUCTATION 1 0.0001
88 SPINAL FRACTURE 1 0.0000
89 PRODUCT PHYSICAL ISSUE 1 0.0000
90 ABDOMINAL PAIN 11 0.0000
91 IMPAIRED WORK ABILITY 1 0.0000
92 LIVER FUNCTION TEST INCREASED 1 0.0000
93 PRODUCT STORAGE ERROR 4 0.0000
94 STEVENS-JOHNSON SYNDROME 1 0.0000
95 RASH MACULO-PAPULAR 1 0.0000
96 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
97 THROAT IRRITATION 2 0.0000
98 ABDOMINAL PAIN UPPER 9 0.0000
99 DYSPHAGIA 4 0.0000
100 LIVER INJURY 1 0.0000
101 PRODUCT COMPLAINT 1 0.0000
102 FLUID RETENTION 2 0.0000
103 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
104 JAUNDICE 1 0.0000
105 SKIN LESION 1 0.0000
106 DIZZINESS 18 0.0000
107 RENAL IMPAIRMENT 3 0.0000
108 BLISTER 2 0.0000
109 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
110 HEADACHE 22 0.0000
111 EYE IRRITATION 2 0.0000
112 LABORATORY TEST ABNORMAL 1 0.0000
113 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
114 VERTIGO 2 0.0000
115 EMOTIONAL DISORDER 1 0.0000
116 MOOD SWINGS 1 0.0000
117 HIP FRACTURE 1 0.0000
118 BLOOD CREATININE INCREASED 2 0.0000
119 ALOPECIA 6 0.0000
120 VIRAL INFECTION 1 0.0000
121 SKIN DISORDER 1 0.0000
122 ABDOMINAL DISCOMFORT 5 0.0000
123 CHEST DISCOMFORT 3 0.0000
124 HEART RATE DECREASED 1 0.0000
125 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
126 C-REACTIVE PROTEIN INCREASED 1 0.0000
127 INJECTION SITE MASS 1 0.0000
128 DYSGEUSIA 2 0.0000
129 DYSARTHRIA 1 0.0000
130 CARDIAC FAILURE 2 0.0000
131 PSORIATIC ARTHROPATHY 1 0.0000
132 OSTEOPOROSIS 1 0.0000
133 VISUAL IMPAIRMENT 3 0.0000
134 RECTAL HAEMORRHAGE 1 0.0000
135 SEPTIC SHOCK 1 0.0000
136 RENAL FAILURE 3 0.0000
137 LIVER DISORDER 1 0.0000
138 VISION BLURRED 3 0.0000
139 TINNITUS 1 0.0000
140 COGNITIVE DISORDER 1 0.0000
141 MULTIPLE SCLEROSIS 1 0.0000
142 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
143 DYSPEPSIA 2 0.0000
144 DRY EYE 1 0.0000
145 DRUG INEFFECTIVE 26 0.0000
146 HAEMOGLOBIN DECREASED 2 0.0000
147 FATIGUE 15 0.0000
148 DEPRESSED MOOD 1 0.0000
149 DIARRHOEA 12 0.0000
150 RASH PRURITIC 1 0.0000
151 OEDEMA 1 0.0000
152 TREATMENT NONCOMPLIANCE 1 0.0000
153 ANAPHYLACTIC REACTION 1 0.0000
154 TREMOR 3 0.0000
155 PANCYTOPENIA 1 0.0000
156 EYE PAIN 1 0.0000
157 NAUSEA 14 0.0000
158 FLATULENCE 1 0.0000
159 BONE PAIN 1 0.0000
160 VOMITING 8 0.0000
161 OEDEMA PERIPHERAL 2 0.0000
162 INJECTION SITE ERYTHEMA 2 0.0000
163 PRODUCT USE ISSUE 3 0.0000
164 LOSS OF CONSCIOUSNESS 2 0.0000
165 FALL 5 0.0000
166 INJECTION SITE PRURITUS 1 0.0000
167 SLEEP DISORDER 1 0.0000
168 HYPERTENSION 3 0.0000
169 THERAPY INTERRUPTED 1 0.0000
170 INFECTION 2 0.0000
171 RASH 6 0.0000
172 WEIGHT INCREASED 3 0.0000
173 HOT FLUSH 1 0.0000
174 UNEVALUABLE EVENT 1 0.0000
175 ACNE 1 0.0000
176 PERIPHERAL SWELLING 2 0.0000
177 BACK PAIN 3 0.0000
178 INJECTION SITE BRUISING 1 0.0000
179 INJECTION SITE HAEMORRHAGE 1 0.0000
180 CARDIAC FAILURE CONGESTIVE 1 0.0000
181 CONFUSIONAL STATE 2 0.0000
182 DRY MOUTH 1 0.0000
183 INFLUENZA LIKE ILLNESS 1 0.0000
184 CARDIAC ARREST 1 0.0000
185 URTICARIA 2 0.0000
186 MYALGIA 2 0.0000
187 INTENTIONAL PRODUCT MISUSE 1 0.0000
188 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
189 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
190 GASTROINTESTINAL DISORDER 1 0.0000
191 BREAST CANCER 1 0.0000
192 CARDIAC DISORDER 1 0.0000
193 ANXIETY 3 0.0000
194 PULMONARY EMBOLISM 1 0.0000
195 GAIT DISTURBANCE 2 0.0000
196 CONTUSION 1 0.0000
197 PAIN IN EXTREMITY 3 0.0000
198 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
199 ILLNESS 1 0.0000
200 PLATELET COUNT DECREASED 1 0.0000
201 CONSTIPATION 2 0.0000
202 INFLUENZA 1 0.0000
203 THROMBOCYTOPENIA 1 0.0000
204 PALPITATIONS 1 0.0000
205 JOINT SWELLING 1 0.0000
206 INSOMNIA 2 0.0000
207 DRY SKIN 1 0.0000
208 ARTHRALGIA 3 0.0000
209 OFF LABEL USE 6 0.0000
210 PRODUCT DOSE OMISSION ISSUE 2 0.0000
211 CONDITION AGGRAVATED 2 0.0000
212 BLOOD PRESSURE INCREASED 1 0.0000
213 ACUTE KIDNEY INJURY 1 0.0000
214 PARAESTHESIA 1 0.0000
215 DRUG INTERACTION 1 0.0000
216 URINARY TRACT INFECTION 1 0.0000
217 MUSCLE SPASMS 1 0.0000
218 CHEST PAIN 1 0.0000
219 HYPERSENSITIVITY 1 0.0000
220 ASTHENIA 2 0.0000
221 BLOOD GLUCOSE INCREASED 1 0.0000
222 ANAEMIA 1 0.0000
223 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
224 DYSPNOEA 2 0.0000
225 INJECTION SITE PAIN 1 0.0000
226 PAIN 2 0.0000
227 PYREXIA 1 0.0000
228 MALAISE 1 0.0000
229 DEATH 1 0.0000